EpiVario
Pre-clinicalEpiVario is an innovation focused biotechnology company that is developing neuroepigenetic modulators to treat memory related addiction and psychiatric disorders.
Founded
2017
Focus
Small Molecules
About
EpiVario is an innovation focused biotechnology company that is developing neuroepigenetic modulators to treat memory related addiction and psychiatric disorders.
Funding History
2Total raised: $1.7M
Grant$225KNational Institutes of HealthJun 15, 2020
Seed$1.5MUniversity City Science CenterAug 15, 2019
Company Info
TypePrivate
Founded2017
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile